Argatroban, a direct thrombin inhibitor for heparin-induced thrombocytopaenia: present and future perspectives

Author： Serebruany Michael V   Malinin Alex I   Serebruany Victor L  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.7, Iss.1, 2006-01, pp. : 81-89

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Argatroban use in heparin-induced thrombocytopenia

By Boggio Lisa N   Oza Veeral M  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 11, 2008-08 ,pp. : 1963-1967

Informa Healthcare

Access to resources Recommend Favorite

Argatroban Anticoagulation for Heparin-Induced Thrombocytopenia in Elderly Patients

By Bartholomew John R.  

Drugs & Aging, Vol. 24, Iss. 6, 2007-01 ,pp. : 489-499

Adis International

Access to resources Recommend Favorite

Argatroban/heparin: Heparin-induced thrombocytopenia and coagulation disorders: case report

By  

Reactions Weekly, Vol. 1, Iss. 1214, 2008-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Argatroban: A Review of its Use in the Management of Heparin-Induced Thrombocytopenia

By Dhillon Sohita  

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 4, 2009-08 ,pp. : 261-282

Adis International

Access to resources Recommend Favorite

Argatroban, specific thrombin inhibitor, induced phenotype change of cultured rabbit vascular smooth muscle cells

By Yoshinaga M.   Sunagawa M.   Shimada S.   Nakamura M.   Murayama S.   Kosugi T.  

European Journal of Pharmacology, Vol. 461, Iss. 1, 2003-02 ,pp. : 9-17

Elsevier

Access to resources Recommend Favorite